利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

64 条记录 (耗时 0.037 秒)

    Devices and methods for occlusion of the uterine arteries
    31.
    发明授权
    Devices and methods for occlusion of the uterine arteries 失效
    用于闭塞子宫动脉的装置和方法

    公开(公告)号：US06764488B1

    公开(公告)日：2004-07-20

    申请号：US09550908

    申请日：2000-04-17

    申请人： Fred Burbank ,  Michael Jones ,  Paul Lubock

    发明人： Fred Burbank ,  Michael Jones ,  Paul Lubock

    IPC分类号： A61B1818

    CPC分类号： A61B8/12 ,  A61B8/06 ,  A61B8/0833 ,  A61B17/12013 ,  A61B17/42 ,  A61B18/1485

    摘要： Devices and methods are disclosed for treating a uterine disorder which receive its blood supply from a uterine artery. In particular, uterine fibroids are effectively treated by occluding the uterine arteries using trans-vaginal, trans-uterine, transrectal, or retroperitoneal approaches. The devices and methods are advantageous because the inventive procedures may be performed by a patient's gynecologist in the course of treatment, avoiding the need for referrals to specialist practitioners and for more radical treatments, such as hysterectomies. The methods include both temporary and permanent occlusion of the arteries. A cannula carries an imaging device and a member which will easily penetrate tissue, the member including a device which partially or completely, and temporarily or permanently, occludes a uterine artery.

    摘要翻译： 公开了用于治疗从子宫动脉接受其血液供应的子宫疾病的装置和方法。 特别地，子宫肌瘤通过使用经阴道，经子宫，经直肠或腹膜后方法闭塞子宫动脉来有效治疗。 所述装置和方法是有利的，因为本发明的方法可以由患者的妇科医生在治疗过程中进行，避免需要转诊给专科医师，以及进行诸如子宫切除术等更激进的治疗。 这些方法包括动脉的临时和永久闭塞。 套管携带成像装置和容易穿透组织的构件，该构件包括部分地或完全地暂时地或永久地阻塞子宫动脉的装置。

    Device and methods for occlusion of the uterine artieries
    32.
    发明授权
    Device and methods for occlusion of the uterine artieries 失效
    用于闭塞子宫手术的装置和方法

    公开(公告)号：US06602251B2

    公开(公告)日：2003-08-05

    申请号：US09835402

    申请日：2001-04-17

    申请人： Fred Burbank ,  Michael Jones ,  Paul Lubock

    发明人： Fred Burbank ,  Michael Jones ,  Paul Lubock

    IPC分类号： A61B1818

    CPC分类号： A61B8/12 ,  A61B8/06 ,  A61B8/0833 ,  A61B17/12013 ,  A61B17/42 ,  A61B18/1485

    摘要： Devices and methods are disclosed for treating a uterine disorder which receive its blood supply from a uterine artery. In particular, uterine fibroids are effectively treated by occluding the uterine arteries using trans-vaginal, trans-uterine, transrectal, or retroperitoneal approaches. The devices and methods are advantageous because the inventive procedures may be performed by a patient's gynecologist in the course of treatment, avoiding the need for referrals to specialist practitioners and for more radical treatments, such as hysterectomies. The methods include both temporary and permanent occlusion of the arteries. A cannula carries an imaging device and a member which will easily penetrate tissue, the member including a device which partially or completely, and temporarily or permanently, occludes a uterine artery.

    摘要翻译： 公开了用于治疗从子宫动脉接受其血液供应的子宫疾病的装置和方法。 特别地，子宫肌瘤通过使用经阴道，经子宫，经直肠或腹膜后方法闭塞子宫动脉来有效治疗。 所述装置和方法是有利的，因为本发明的方法可以由患者的妇科医生在治疗过程中进行，避免需要转诊给专科医师，以及进行诸如子宫切除术等更激进的治疗。 这些方法包括动脉的临时和永久闭塞。 套管携带成像装置和容易穿透组织的构件，该构件包括部分地或完全地暂时地或永久地阻塞子宫动脉的装置。

    AUTOMATED SYSTEM FOR CRYOPRESERVATION OF OOCYTES, EMBRYOS, OR BLASTOCYSTS
    34.
    发明申请
    AUTOMATED SYSTEM FOR CRYOPRESERVATION OF OOCYTES, EMBRYOS, OR BLASTOCYSTS 审中-公开
    OOCYTES，EMBRYOS或BLASTOCYST的CRYOPRESOV自动化系统

    公开(公告)号：US20110207112A1

    公开(公告)日：2011-08-25

    申请号：US13055134

    申请日：2009-07-22

    申请人： Fred Burbank ,  Michael Jones

    发明人： Fred Burbank ,  Michael Jones

    IPC分类号： C12Q3/00 ,  C12M3/00 ,  C12N5/075 ,  C12Q1/02 ,  C12N5/073 ,  C12M1/34 ,  G05D7/00 ,  G06F19/00

    CPC分类号： A01N1/0221 ,  A01N1/0252

    摘要： An automated system and method of cryopreservation and reanimation of oocytes, embryos, or blastocysts is disclosed. One or more oocytes or embryos are positioned in a processing container, the processing container being configured to allow fluid to flow into and out of the processing container, where two or more fluids flow into and out of the processing container with oocytes or embryos therein. The temperature of the fluid may be controlled in the processing container according to predetermined requirements. The flowing of the fluids may be controlled by a central controller adapted to control one or more valves.

    摘要翻译： 公开了一种卵母细胞，胚胎或囊胚的冷冻保存和再生的自动化系统和方法。 一个或多个卵母细胞或胚胎定位在处理容器中，处理容器构造成允许流体流入和流出处理容器，其中两个或更多个流体流入和流出处理容器，其中卵母细胞或胚胎在其中。 流体的温度可以根据预定的要求在处理容器中进行控制。 流体的流动可以由适于控制一个或多个阀的中央控制器来控制。

    METHODS FOR MINIMALLY INVASIVE, NON-PERMANENT OCCLUSION OF A UTERINE ARTERY
    36.
    发明申请
    METHODS FOR MINIMALLY INVASIVE, NON-PERMANENT OCCLUSION OF A UTERINE ARTERY 审中-公开
    用于微量入侵，非永久性肛门动脉闭塞的方法

    公开(公告)号：US20080200924A1

    公开(公告)日：2008-08-21

    申请号：US12107652

    申请日：2008-04-22

    申请人： Fred Burbank ,  Greig E. Altieri ,  Michael L. Jones

    发明人： Fred Burbank ,  Greig E. Altieri ,  Michael L. Jones

    IPC分类号： A61B17/42

    CPC分类号： A61B17/12136 ,  A61B17/12009 ,  A61B17/12022 ,  A61B17/1204 ,  A61B17/12186 ,  A61B17/1219 ,  A61B2017/00004 ,  A61B2017/4216 ,  A61K31/045 ,  A61K31/10 ,  A61K31/734 ,  A61K45/06 ,  A61L24/0031 ,  A61L24/0042

    摘要： A method of treating a uterine disorder comprising non-permanently occluding a uterine artery with a resorbable embolic mass for a therapeutically effective time period. The occluding step includes selectively positioning the resorbable embolic mass within the uterine artery, and monitoring positioning of the resorbable embolic mass at a desired location within the uterine artery. The monitoring step may include using ultrasound or magnetic resonance imaging (MRI) for positioning the resorbable embolic mass at the desired location within the uterine artery. The resorbable embolic mass may be swellable and may be formed of a polymeric material selected from the group consisting of polylactic acid, polyglycolic acid, polyethylene glycol, or copolymers thereof.

    摘要翻译： 一种治疗子宫疾病的方法，包括非永久性闭塞具有可吸收栓塞物质的子宫动脉用于治疗有效时间段。 闭塞步骤包括将可再吸收的栓塞质量选择性地定位在子宫动脉内，以及监测可再吸收的栓塞物质在子宫动脉内的期望位置的定位。 监测步骤可以包括使用超声或磁共振成像（MRI）来将可再吸收的栓塞物质定位在子宫动脉内的期望位置。 可再吸收的栓塞质量可以是可溶胀的，并且可以由选自聚乳酸，聚乙醇酸，聚乙二醇或其共聚物的聚合材料形成。

    Methods and Devices for Automated Biopsy and Collection of Soft Tissue
    37.
    发明申请
    Methods and Devices for Automated Biopsy and Collection of Soft Tissue 失效
    自动活组织检查和软组织收集的方法和装置

    公开(公告)号：US20070156064A1

    公开(公告)日：2007-07-05

    申请号：US11671500

    申请日：2007-02-06

    申请人： Mark Ritchart ,  J. Michael Stuart ,  Fred Burbank ,  Kenneth Galt

    发明人： Mark Ritchart ,  J. Michael Stuart ,  Fred Burbank ,  Kenneth Galt

    IPC分类号： A61B10/00

    CPC分类号： A61B10/0266 ,  A61B6/12 ,  A61B8/0841 ,  A61B10/0275 ,  A61B10/0283 ,  A61B17/221 ,  A61B2010/0208 ,  A61B2010/0225 ,  A61B2017/303

    摘要： Instruments for performing percutaneous biopsy procedures are disclosed, which have advantageous features for improving functionality and performance over prior art devices. These instruments comprise two types, single-use devices, and multiple-use devices having active tissue capture capability. Improved features include the ability to retrieve and evaluate multiple tissue samples during a single insertion procedure, without physical handling of the samples, as well as constructional features, such as a molded tissue cassette housing, variant vacuum port embodiments suited for different tissue environments, and a method for backflushing the instrument to remove biological debris, among others.

    摘要翻译： 公开了用于执行经皮活检程序的仪器，其具有改善现有技术装置的功能和性能的有利特征。 这些仪器包括两种类型的一次性装置，以及具有活性组织捕获能力的多用途装置。 改进的特征包括在单次插入过程中检索和评估多个组织样本的能力，而不对样品进行物理处理，以及结构特征，例如模制的组织盒壳体，适合于不同组织环境的变体真空端口实施例，以及 一种用于反吹仪器以去除生物碎屑的方法等。

    Methods for minimally-invasive, non-permanent occlusion of a uterine artery
    38.
    发明申请
    Methods for minimally-invasive, non-permanent occlusion of a uterine artery 失效

    公开(公告)号：US20060000479A9

    公开(公告)日：2006-01-05

    申请号：US09908815

    申请日：2001-07-20

    申请人： Fred Burbank ,  Greig Altieri ,  Michael Jones

    发明人： Fred Burbank ,  Greig Altieri ,  Michael Jones

    IPC分类号： A61B19/00

    CPC分类号： A61B17/12009 ,  A61B17/12 ,  A61B17/2812 ,  A61B17/282 ,  A61B17/42 ,  A61B17/4241

    摘要： Non-permanent occlusion of the uterine arteries is sufficient to cause the demise of uterine myomata without unnecessarily exposing other tissues and anatomical structures to hypoxia attendant to prior permanent occlusion techniques. A therapeutically effective transient time of occlusion of a uterine artery to treat uterine fibroid tumors is from 1 hours to 24 hours, and preferably is at least about 4 hours. A therapeutically effective temporary time of occlusion of a uterine artery to treat uterine fibroid tumors is from 1 day (24 hours) to 7 days (168 hours), and preferably is about 4 days (96 hours). By invaginating the tissues of the vaginal wall up to or around a uterine artery, collapse of the uterine artery can be achieved without penetrating tissue of the patient.

    Methods for marking a biopsy site
    39.
    发明申请
    Methods for marking a biopsy site 有权
    标记活检部位的方法

    公开(公告)号：US20050049489A1

    公开(公告)日：2005-03-03

    申请号：US10966551

    申请日：2004-10-15

    申请人： Seth Foerster ,  Fred Burbank ,  Mark Ritchart ,  Elias Zerbouni

    发明人： Seth Foerster ,  Fred Burbank ,  Mark Ritchart ,  Elias Zerbouni

    IPC分类号： A61B10/02 ,  A61B10/00 ,  A61B17/00 ,  A61B19/00 ,  A61N5/00

    CPC分类号： A61B19/54 ,  A61B10/0275 ,  A61B10/0283 ,  A61B90/39 ,  A61B2017/00004 ,  A61B2090/3908 ,  A61B2090/3987 ,  Y10T24/4501

    摘要： Implantable devices and methods of use are disclosed for marking the location of a biopsy or surgery for the purpose of identification. The methods include providing a biodegradable radiodense implant and taking a tissue sample from a biopsy site within a breast of a patient. The biodegradable implant is then positioned at the biopsy site. The tissue sample is tested and the biopsy site is then relocated. In one embodiment, the entire implant is radiodense. In another embodiment, the entire implant is biodegradable. Methods of using a biodegradable implant having a radiodense material and a biodegradable implant that is visible using an imaging system are also included.

    摘要翻译： 公开了可植入装置和使用方法，用于标识活检或手术的位置用于鉴定。 所述方法包括提供可生物降解的放射线植入物并从患者乳房内的活检部位取出组织样品。 然后将可生物降解的植入物置于活检部位。 测试组织样品，然后将活检部位重新定位。 在一个实施例中，整个植入物是辐射二极管。 在另一个实施方案中，整个植入物是可生物降解的。 还包括使用具有放射性物质的可生物降解植入物和使用成像系统可见的可生物降解植入物的方法。

    Sleep apnea therapy with naso-phyrangeal bypass
    40.
    发明授权
    Sleep apnea therapy with naso-phyrangeal bypass 有权
    睡眠呼吸暂停治疗与鼻 - 泛素旁路

    公开(公告)号：US08568438B2

    公开(公告)日：2013-10-29

    申请号：US12725875

    申请日：2010-03-17

    申请人： Fred Burbank ,  Mike Jones ,  Al Memmolo

    发明人： Fred Burbank ,  Mike Jones ,  Al Memmolo

    IPC分类号： A61M29/00 ,  A61M15/08

    CPC分类号： A61F5/56 ,  A61B17/24 ,  A61F2/203 ,  A61F5/08 ,  A61M15/08 ,  A61M15/085 ,  A61M16/0461

    摘要： Naso-pharyngeal devices for treating sleep apnea can perform two functions simultaneously: keeping an open airway through an inner lumen of the device; and support for the tissue in the airway, because keeping the tissue from completely collapsing creates the possibility of some air movement around the device in the critical areas associated with obstructive sleep apnea.

    摘要翻译： 用于治疗睡眠呼吸暂停的鼻咽装置可以同时执行两个功能：保持开放的气道通过装置的内腔; 并且支持气道中的组织，因为保持组织完全塌陷，导致在与阻塞性睡眠呼吸暂停相关联的关键区域中的装置周围的一些空气移动的可能性。